LakeShore Biopharma Co (LSBCF) Total Assets by Year
LakeShore Biopharma Co closed fiscal year 2025 with $190.5M in total assets, $120.9M in total liabilities and $69.6M in shareholder equity. Total assets fell 10.7% from the prior fiscal year. The table below carries 5 fiscal years, from 2021 to 2025, and the quarters LakeShore Biopharma Co has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
LSBCF Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
LSBCF Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More LakeShore Biopharma Co financials
Frequently Asked Questions
LakeShore Biopharma Co closed fiscal year 2025 with $190.5M in total assets, $120.9M in total liabilities and $69.6M in shareholder equity.
LakeShore Biopharma Co (LSBCF) total assets fell by 10.7% year over year, from $213.3M to $190.5M in fiscal year 2025.
LakeShore Biopharma Co (LSBCF) reported $190.5M in total assets in Q4 2025. This represents a decrease of 10.7% from the same quarter a year earlier.
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what LakeShore Biopharma Co (LSBCF) reported on that line in every period on record.